Pacs (PACS) EBITDA (2023 - 2026)

Pacs (PACS) has 4 years of EBITDA data on file, last reported at $120.0 million in Q1 2026.

• Quarterly EBITDA rose 321.59% year-over-year to $120.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $352.0 million (up 285.34% YoY) and the FY2025 annual result came in at $309.6 million, up 151.55% from the prior year.
• EBITDA advanced to $120.0 million in Q1 2026 per PACS's latest filing, from $94.7 million in the prior quarter.
• The five-year high for EBITDA was $120.0 million in Q1 2026, with the low at -$32.1 million in Q2 2024.
• Average EBITDA over 4 years is $48.9 million, with a median of $37.6 million recorded in 2023.
• Year-over-year, EBITDA plunged 251.19% in 2024 and soared 321.59% in 2026.
• Pacs' EBITDA stood at $62.5 million in 2023, then increased by 15.1% to $72.0 million in 2024, then surged by 31.55% to $94.7 million in 2025, then rose by 26.77% to $120.0 million in 2026.
• Business Quant data shows PACS's EBITDA at $120.0 million in Q1 2026, $94.7 million in Q4 2025, and $86.3 million in Q3 2025.